Intraductal Papillary Mucinous Adenocarcinoma of the Pancreas: Clinical Outcomes, Prognostic Factors, and the Role of Adjuvant Therapy

BACKGROUND: Pancreatic ductal adenocarcinoma (PDAC) arising in intraductal papillary mucinous neoplasms (IPMN) may represent a different biologic entity than classic PDAC, and there is little evidence to inform adjuvant treatment decisions. The purpose of this study was to identify prognostic factor...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Alexander, Brian M., Fernandez-del Castillo, Carlos, Ryan, David P., Kachnic, Lisa A., Hezel, Aram F., Niemierko, Andrzej, Willett, Christopher G., Kozak, Kevin R., Blaszkowsky, Lawrence S., Clark, Jeffrey W., Warshaw, Andrew L., Hong, Theodore S.
Format: Artigo
Sprache:Inglês
Veröffentlicht: International Society of Gastrointestinal Oncology 2011
Schlagworte:
Original Research
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC3283102/
https://ncbi.nlm.nih.gov/pubmed/22368734
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge